Opinion

It’s never been more important to talk about vaccines, says head of pharma organisation

11 November 2020

Richard Torbett, Chief Executive, ABPI says vaccines are one of our best hopes for eradicating COVID-19 and why the ABPI is launching a campaign to highlight this. “COVID-19 has put shone a spotlight on the pharmaceutical industry like never before. Millions of people all over the world are living under some form of restrictions.  The […]

Human models for human drug development

14 October 2020

By FRAME (Fund for the Replacement of Animals in Medical Experiments) CEO, Celean Camp, FRAME Alternatives Laboratory Director, Dr Andrew Bennett and FRAME Scientific Liaison Officer, Amy Beale. Animals remain the first choice for testing and research in drug discovery and development, despite scientific advances across a range of other methodologies, and some tightening of […]

What can we learn from COVID-19 to shape future EU pharmaceutical policy?

13 October 2020

Adrian van den Hoven, Director General, Medicines for Europe, looks at how COVID-19 has altered the way we consider EU pharmaceutical policy Adrian van den Hoven delivered the opening keynote address at the CPhI Festival of Pharma on how COVID-19 is changing the landscape of European pharmaceutical policy, primarily with regard to supply chain security. […]

Sitting down with…Biorelate

28 September 2020
By Lu Rahman

Daniel Jamieson is the CEO and Founder of Biorelate, a biomedical curation company that aims to accelerate insight and innovation in drug discovery. Lu Rahman spoke to him about his vision for the business, how COVID-19 has affected the landscape and the technology behind his drug discovery success. Biorelate was founded in 2014 from scientific […]

Social distancing shows us we’re better together

28 September 2020
By Lu Rahman

What a time to be involved in drug discovery. While COVID-19 has of course created unprecedented conditions on a global scale, it has also highlighted the extent to which this sector offers depth of knowledge, skill and innovation. It is a pleasure to learn more about the market – both COVID and non-COVID – and […]

Why metabolomics has the potential to transform diagnosis and treatment

13 September 2020
By Lu Rahman

Lu Rahman speaks to key members of Metabolon on the company’s pioneering work in metabolomics including its innovative collaborations with DNAGenotek and the Institute for Systems Biology. “Metabolon has built an unrivalled global biochemical profiling platform capable of providing metabolite data of unsurpassed quality and coverage,” says Brian Keppler, PhD, Director, Discovery and Translational Sciences at […]

From the football field to the world of biotech

10 September 2020
By Dr Darrin M Disley, CEO of Mogrify

Dr Darrin M Disley, CEO of Mogrify, knows his way around a football field and will be speaking at Drug Discovery Digital. A serial biotech entrepreneur, Disley was once told he wasn’t good enough to study chemistry, so he momentarily chose football. Fast forward to October 2020, he will be giving the plenary keynote address […]

Opinion: UK health system restructuring and its effect on drug development

1 September 2020
By Martyna Giedrojc, Associate Director at RPP Group UK

While everyone’s attention is focused on efforts to contain COVID-19, few probably noticed signs that the UK health system is about to undergo some major changes that will have an impact on both patients and the healthcare industry as early as next year. In preparation for the end of the Brexit transition period, the UK government […]

« Previous

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free